Results 191 to 200 of about 57,833 (235)

Aggressive Plattenepithelkarzinome auf dem Boden eines Lichen ruber mucosae: Bericht über drei Fälle

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 8, Page 1129-1133, August 2026.
Neda Cramer, Dagmar Wilsmann‐Theis, Michael P. Schön, Jörg Wenzel, Julia Gallwas, Rotraut Mössner   +5 more
wiley   +1 more source

Uncommon Case of Hemophagocytic Lymphohistiocytosis as the First Presentation of Systemic Lupus Erythematosus. [PDF]

ACG Case Rep J
Tummala S, Wu A, Lin YN, Price T, Demetris A, Celaj S.   +5 more
europepmc   +1 more source

A Successful Monitoring of a Pregnant Woman Suffering from Mixed Connective Tissue Disease-Associated Interstitial Lung Disease: A Case Report. [PDF]

Int J Womens Health
Cui X, Zhou W, Sun Y, Duan Y, Sun H.
europepmc   +1 more source

Acute Massive Hydroxychloroquine Overdose of 60 g in an Adult, Successfully Resuscitated: A Successful Salvage. [PDF]

Case Rep Crit Care
Vora A, Wong A, Brown A.
europepmc   +1 more source

Multisystemic Granulomatosis Induced by Red Tattoo Pigment: Course Over 10 Years. [PDF]

Cureus
Cathebras P, Habougit C, Grange S, Catinon M, Vincent M.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hydroxychloroquine and Cardiotoxicity

Cardiology in Review, 2023
Hydroxychloroquine (HCQ) has been used for rheumatological diseases such as systemic lupus erythematous and rheumatoid arthritis and demonstrated to improve clinical symptoms and reduce long-term sequelae. The drug is metabolized in the liver, is primarily excreted through the kidney, and works by modulating major histocompatibility complex (MHC) and ...
Subo, Dey, Kyu-In, Lee, Sarah, Subhan, Julia Yegudin, Ash, Amy, Wasserman, William H, Frishman, Wilbert S, Aronow   +6 more
openaire   +2 more sources

Hydroxychloroquine and the Retina

JAMA, 2015
Hydroxychloroquine sulfate is widely prescribed in the treatment of systemic lupuserythematosus (SLE), rheumatoidarthritis, and related autoimmunediseases, and it has largely superseded the use of chloroquinephosphate for these conditions. Furthermore, hydroxychloroquine isnowbeingevaluated forothermedical uses, including controlofbloodglucose ...
Michael F, Marmor, Ronald B, Melles
openaire   +2 more sources

Hydroxychloroquine Retinopathy

American Journal of Ophthalmology, 1991
We analyzed ocular findings from two patients (aged 49 and 60 years) with hydroxychloroquine (Plaquenil, Winthrop Pharmaceuticals, Division of Sterling Drug, Inc., New York, New York) retinopathy. Both patients were treated for systemic lupus erythematosus; one patient was treated with 400 to 800 mg of hydroxychloroquine per day (6.1 to 12.2 mg/kg of ...
A, Weiner, M A, Sandberg, A R, Gaudio, M M, Kini, E L, Berson   +4 more
openaire   +2 more sources

Safety of Hydroxychloroquine

Archives of Ophthalmology, 1982
To the Editor. —The article by Tobin et al published in the JanuaryArchives(1982;100:81-83) on the safety of hydroxychloroquine sulfate recalls my experience with this drug in rheumatic diseases. During the past 15 years, I have followed up approximately 100 patients with rheumatoid arthritis and lupus erythematosus who were given hydroxychloroquine ...
openaire   +2 more sources

Hydroxychloroquine

Reactions Weekly, 2020
  +8 more sources